The Relationship Between Serum Cytokine Levels and the Degree of Psychosis and Cognitive Impairment in Patients With Methamphetamine-Associated Psychosis in Chinese Patients

Copyright © 2020 Yang, Zhao, Liu, Xie, Zhou, Deng and Wang..

Background: Cytokine levels can be changed in methamphetamine (METH) use disorders (MUDs) and primary psychosis. The present study assessed serum levels of some kinds of interleukins (ILs) in METH-associated psychosis (MAP) and their relationships with psychotic symptoms and cognitive dysfunction. Methods: Serum IL-2R, IL-6, IL-8, and IL-10 levels were examined by chemiluminescence assays in MAP patients (n = 119) and healthy controls (n = 108). The Positive and Negative Syndrome Scale (PANSS) and Montreal Cognitive Assessment (MOCA) were administered. Results: Serum levels of IL-6 and IL-8 were significantly increased in MAP patients (all p < 0.05). There was a negative relationship between IL-2R levels and PANSS positive (P) subscale scores (r = -0.193, p = 0.035). IL-6, IL-8 and IL-10 levels were all negatively correlated with the naming, delayed recall and orientation subscores on the MOCA (r = -0.209, p = 0.022; r = -0.245, p = 0.007; r = -0.505, p < 0.001, respectively). Conclusions: Our results indicate that immune disturbances are related to MAP and that IL-2R, IL-6, IL-8, and IL-10 are associated with the severity of psychotic symptoms and cognitive function impairment.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Frontiers in psychiatry - 11(2020) vom: 01., Seite 594766

Sprache:

Englisch

Beteiligte Personen:

Yang, Xue [VerfasserIn]
Zhao, Hui [VerfasserIn]
Liu, Xuebing [VerfasserIn]
Xie, Qin [VerfasserIn]
Zhou, Xiaoliang [VerfasserIn]
Deng, Qijian [VerfasserIn]
Wang, Gang [VerfasserIn]

Links:

Volltext

Themen:

Addiction
Cognitive
Journal Article
Methamphetamine
Psychosis
Serum cytokine

Anmerkungen:

Date Revised 29.12.2020

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.3389/fpsyt.2020.594766

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM319269132